- Home
- IMUX vs NSTS Comparison
IMUX vs NSTS Comparison
Compare IMUX & NSTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMUX
- NSTS
- Stock Information
- Founded
- IMUX 2016
- NSTS 1921
- Country
- IMUX United States
- NSTS United States
- Employees
- IMUX N/A
- NSTS N/A
- Industry
- IMUX Biotechnology: Pharmaceutical Preparations
- NSTS Savings Institutions
- Sector
- IMUX Health Care
- NSTS Finance
- Exchange
- IMUX Nasdaq
- NSTS Nasdaq
- Market Cap
- IMUX 67.8M
- NSTS 65.5M
- IPO Year
- IMUX N/A
- NSTS N/A
- Fundamental
- Price
- IMUX $0.96
- NSTS $12.01
- Analyst Decision
- IMUX Strong Buy
- NSTS
- Analyst Count
- IMUX 5
- NSTS 0
- Target Price
- IMUX $7.50
- NSTS N/A
- AVG Volume (30 Days)
- IMUX 1.1M
- NSTS 3.3K
- Earning Date
- IMUX 08-11-2025
- NSTS 08-08-2025
- Dividend Yield
- IMUX N/A
- NSTS N/A
- EPS Growth
- IMUX N/A
- NSTS N/A
- EPS
- IMUX N/A
- NSTS N/A
- Revenue
- IMUX N/A
- NSTS $9,115,000.00
- Revenue This Year
- IMUX N/A
- NSTS N/A
- Revenue Next Year
- IMUX N/A
- NSTS N/A
- P/E Ratio
- IMUX N/A
- NSTS N/A
- Revenue Growth
- IMUX N/A
- NSTS 78.72
- 52 Week Low
- IMUX $0.56
- NSTS $9.37
- 52 Week High
- IMUX $2.11
- NSTS $13.32
- Technical
- Relative Strength Index (RSI)
- IMUX 55.60
- NSTS 44.58
- Support Level
- IMUX $0.94
- NSTS $12.02
- Resistance Level
- IMUX $1.18
- NSTS $12.39
- Average True Range (ATR)
- IMUX 0.08
- NSTS 0.13
- MACD
- IMUX 0.01
- NSTS -0.01
- Stochastic Oscillator
- IMUX 40.95
- NSTS 44.23
About IMUX Immunic Inc.
Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function.
About NSTS NSTS Bancorp Inc.
NSTS Bancorp Inc is a savings and loan holding company regulated Federal Reserve Board. The company was formed to serve as the North Shore Trust and Savings stock holding company. The Bank is a wholly-owned subsidiary of the company and operates as a traditional savings institution focused on serving the banking needs of customers in market area of Lake County, Illinois and adjacent communities.